Although these concentrations were lower than the suggested effective dose [20, 21], the PR3-ANCA titer was still reduced sufficiently to maintain remission of the ANCA-associated vasculitis. Here, PRTN3 is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.